Learn more about ACRO’s advocacy efforts in the United States and Europe
Artificial Intelligence & Machine Learning
ACRO’s AI/ML Committee brings together member company subject matter experts engaged in the development and use of AI/ML tools in the design, conduct, oversight, and analysis of clinical trials.
Diversity & Inclusion in Clinical Trials
ACRO’s Diversity and Inclusion in Clinical Trials Committee was formed in 2020 as a part of ACRO’s ongoing efforts to work towards advancing diversity, equity, and inclusion in the clinical research ecosystem.
Risk-Based Quality Management
Risk-based monitoring is an adaptive approach that directs monitoring focus and activities to the evolving areas of greatest need which have the most potential to impact patient safety and data quality.
ACRO MEMBERS
US Advocacy
ACRO works with US legislators and regulators to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research.
European Advocacy
ACRO engages with regulators and policymakers in the EU and UK to ensure a positive regulatory environment that supports high-quality, safe and ethical clinical research.
Subscribe for Updates
The Association of Clinical Research Organizations (ACRO) represents the leading clinical research and technology companies around the world. In our newsletter, we bring you updates on our work and the impact that we are having in advancing the global clinical research industry.
The Latest
FDA Changes and Implications: What You Need to Know
In late March, a wave of changes at HHS and the FDA marked the beginning…
Good Clinical Podcast – Season 3, Episode 6: Strategic Uses of AI in Clinical Development
Episode 6: Strategic Uses of AI in Today’s Clinical Development Malaikannan Sankarasubbu and Jonathan Shough join the Good Clinical…
New Report: ACRO Members’ Impact on the Industry
ACRO’s 2024 Member Demographics Survey Highlights Industry Impact In early 2025, ACRO conducted a survey of its…
Good Clinical Podcast – Season 3, Episode 5: The Future of Rare Disease Research
Episode 5: Rethinking Rare – The Future of Rare Disease Research Join us for this…
Good Clinical Podcast – Season 3, Episode 4: What Matters Most in Clinical Trial Monitoring
Episode 4: Maximizing Methods for Clinical Trial Monitoring What does clinical trial monitoring have in…
Good Clinical Podcast – Season 3, Episode 3: Future-Proofing Drug Development
Episode 3: Future-Proofing Drug Development On this week’s episode, Lisa Moneymaker (SVP, Head of Strategic Customer Engagement, Medidata…
Good Clinical Podcast – Season 3, Episode 2: Centralized Monitoring in Action: Case Studies From the Field
Episode 2 – Centralized Monitoring in Action: Case Studies from the Field On this week’s…